US Stock MarketDetailed Quotes

HIMS Hims & Hers Health

Watchlist
  • 29.050
  • -0.500-1.69%
Trading Apr 1 10:24 ET
6.45BMarket Cap54.81P/E (TTM)

About Hims & Hers Health Company

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Company Profile

SymbolHIMS
Company NameHims & Hers Health
Listing DateSep 13, 2019
Founded2017
CEOMr. Andrew Dudum
MarketNYSE
Employees1637
Fiscal Year Ends12-31
Address2269 Chestnut Street,Suite 523
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94123
Phone1-415-851-0195
Websitehttp://www.forhims.com

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Dudum
  • Chief Executive Officer and Chairman of the Board
  • 14.40M
  • Soleil Boughton
  • Chief Legal Officer and Corporate Secretary
  • 5.21M
  • Melissa Baird
  • Chief Operating Officer
  • 6.77M
  • Mike Chi
  • Chief Commercial Officer
  • 6.71M
  • Oluyemi Okupe
  • Chief Financial Officer
  • 7.43M
  • Dr. Patrick Carroll, M.D.
  • Director and Chief Medical Officer
  • 198.26K
  • Irene Becklund
  • Principal Accounting Officer, Senior Vice President and Controller
  • --
  • Deborah M. Autor
  • Independent Director
  • --
  • Christiane Pendarvis
  • Independent Director
  • 715.39K
  • Anja L. Manuel
  • Independent Director
  • --
  • Andrea G. Perez Garcia
  • Independent Director
  • 205.51K
  • Kare Schultz
  • Independent Director
  • --
  • David Bolling Wells
  • Lead Independent Director
  • 227.41K
  • Christopher D. Payne
  • Independent Director
  • --
  • Dr. Delos Cosgrove, M.D.
  • Independent Director
  • 194.26K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Trump's comeback to the Office

Following Trump's Policies to Seek Investment Opportunities

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025